results of a phase i trial investigating cynk-001, a placental nk-cell product, in patients with aml

Published 5 months ago • 172 plays • Length 2:49

Download video MP4
Download video MP3

Similar videos

1:39

update on a phase i/ii study of ziftomenib in patients with r/r aml
2:41

a phase i/ii study of afm13 in combination with cord blood-derived nk cells in patients with r/r hl
2:12

results from phase i study of alnuctamab administered intravenously & subcutaneously in r/r myeloma
2:05

investigating mutation order in aml using single-cell sequencing
4:54

imugene reports promising results in phase 1b trial for azer-cel in dlbcl
1:25

preliminary results from a phase ib trial of as-1763, a novel non-covalent btki, in cll/mcl
55:57

defining regeneration and non-regeneration at a cellular and molecular level
42:37

flow cytometry basics: overcome technical challenges [webinar]
48:52

natural killer cells remember - lewis lanier
0:59

next steps for gene-edited nk cells in the treatment of hematological malignancies
2:41

cell avidity as a predictor of t-cell efficacy
2:41

an overview of the latest advances in hematology
1:19

gene editing of nkg2a to enhance nk cell cytotoxicity against multiple myeloma cells
2:34

results from a single-cell spatial analysis of the renal al amyloidosis immunome
0:28

label-free live cell imaging: t-cells killing cancer cells - zoomed-in
3:40

results of a study evaluating the predictive power of fish markers for pfs in al amyloidosis
0:55

a pooled analysis to determine the optimal ki-67 index cut-off point for predicting outcomes in mcl
1:21

the correlation between jak2v617f molecular response and efs in patients with early pv
0:57

using single-cell rna sequencing & proteomics to identify novel cell surface targets in aml
3:46

variant allele frequency in patients with sf3b1-mutated mds
1:57

perspectives on allogeneic nk cell-based immunotherapy
2:01

flow cytometry-based cytotoxicity assay to assess nk cell activity | protocol preview

Clip.africa.com - Privacy-policy